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Abstract
Recent genome-wide (GW) scans have identified several independent loci affecting human stature, but their contribution
through the different skeletal components of height is still poorly understood. We carried out a genome-wide scan in 12,611
participants, followed by replication in an additional 7,187 individuals, and identified 17 genomic regions with GW-
significant association with height. Of these, two are entirely novel (rs11809207 in CATSPER4, combined P-value = 6.161028
and rs910316 in TMED10, P-value = 1.461027) and two had previously been described with weak statistical support
(rs10472828 in NPR3, P-value = 361027 and rs849141 in JAZF1, P-value = 3.2610211). One locus (rs1182188 at GNA12)
identifies the first height eQTL. We also assessed the contribution of height loci to the upper- (trunk) and lower-body (hip
axis and femur) skeletal components of height. We find evidence for several loci associated with trunk length (including
rs6570507 in GPR126, P-value = 461025 and rs6817306 in LCORL, P-value = 461024), hip axis length (including rs6830062 at
LCORL, P-value = 4.861024 and rs4911494 at UQCC, P-value = 1.961024), and femur length (including rs710841 at PRKG2, P-
value = 2.461025 and rs10946808 at HIST1H1D, P-value = 6.461026). Finally, we used conditional analyses to explore a
possible differential contribution of the height loci to these different skeletal size measurements. In addition to validating
four novel loci controlling adult stature, our study represents the first effort to assess the contribution of genetic loci to
three skeletal components of height. Further statistical tests in larger numbers of individuals will be required to verify if the
height loci affect height preferentially through these subcomponents of height.
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Introduction
Body height is determined by several biological processes that
occur throughout the life of an individual and involve both normal
and pathological growth. Most skeletal bones are formed by
endochondral ossification, the process of replacing hyaline
cartilage with bony tissue. Ossification starts shortly after gestation
at the diaphysis and extends along the end of the long bones.
Growth continues throughout childhood via mitotic division of the
cartilage at the distal surface of the epiphysis and the epiphyseal
plate, accelerates during the adolescence growth spurt and slows
down in the early twenties, when the epiphyseal plate completely
ossifies and peak body height is achieved. Subsequent decreases in
peak body height throughout life are mainly the consequence of
vertebral bone deformities such as crush fractures (osteoporosis)
and cartilage degeneration (osteoarthritis).
Epidemiological studies have revealed marked differences in the
growth patterns for the lower and upper portions of the body. Both
trunk and lower limb length are associated with parental height,
birth weight and weight at age 4 years [1]. Leg length, the
principal determinant of final height attainment in adults [2], is
positively associated with advantaged socio-economical circum-
stances and nutritional intake in childhood [1,3,4]. Leg length is
also largely responsible for the secular increase in height in some
populations [5]. Conversely, trunk length is not correlated with
nutrient intake in children, and has been shown to be negatively
correlated with psychophysical stress [1]. This evidence suggests
that independent growth pathways might be in part responsible for
final upper and lower body size.
Recent, well-powered genome-wide association (GWA) scans
have already identified 43 independent loci associated with height,
revealing a significant overrepresentation of genes controlling
DNA replication, intracellular signalling, cell division and
mesoderm and skeletal development [6–10]. We have carried
out an independent meta-analysis of stature to assess the
contribution of genetic loci to overall body height. In addition,
we have investigated for the first time the contribution of these
height loci to leg and trunk length using derived measurements of
skeletal frame size and we have used conditional analyses to
explore a possible differential contribution of the height loci to the
different skeletal measurements.
Results
Associations with Height
To search for loci influencing adult height we analyzed genome-
wide (GW) data for 299,216 SNPs from a combined sample of
12,611 adults of Caucasian origin from the UK (EPIC Norfolk,
n = 3,211; TwinsUK, n = 2,224; 1958 Birth Cohort, n = 1,430)
and the Netherlands (Rotterdam Study, n = 5,746) genotyped with
Human300 and 550 bead arrays (Illumina) (Figure S1). We note
that the EPIC Norfolk sample was also included in a recent meta-
analysis for height, where the same individuals were genotyped
using the 500 K Gene chip (Affymetrix) [9]. Although our
discovery set was not entirely independent from the Weedon et
al study, inclusion of this collection in the discovery set can provide
further support to validate other genomic regions in conjunction
with other sample collections. In total, 86 SNPs from 35 genomic
regions reached significance with P-values,1025 in the full set of
12,611 individuals; in the independent discovery set of 9,400
individuals (excluding EPIC, due to its previous use) 57 SNPs from
20 genomic regions were significant at this threshold. We selected
52 SNPs from the 35 regions for replication genotyping in an
additional 4,275 samples from three population cohorts (Twin-
sUK, Chingford and Chuvasha). In addition, we genotyped a
subset of 31 SNPs highly suggestive of true association but that did
not reach GW-significance in the first replication set in additional
2,912 individuals with height data from the CBR cohort (Table 1;
details of the cohorts are given in Table S1). A total of seventeen
independent signals reached GW-significance (P-value#561027)
in the combined dataset, and seven additional loci had suggestive
evidence for association with height (561027#P-value,1025,
Table 1 and Table S2).
Two of the seventeen loci that reached GW-significant
association are novel. The SNP rs11809207 is located in the third
intron of the CATSPER4 gene (combined P-value = 6.161028).
The A allele at rs11809207 was associated with an increase in
height of 0.071 (95% C.I. 0.044–0.098) standard deviations,
corresponding to an effect size of 0.46 cm per copy of the allele.
Two nearby SNPs are in high LD with rs11809207 and have
marginally higher P-values in the meta-analysis (rs2783711 near
PDIK1L, P-value = 5.761025, r2 = 0.61 in the HapMap CEU
sample; and rs12069719, P-value = 3.761025, r2 = 0.6; Figure
S2A). The lead SNP of the second locus rs910316 (P-
value = 1.461027) is located in the first intron of TMED10 (Figure
S2O). The A allele is associated with an increase in height of 0.053
(95% C.I. 0.031–0.075) standard deviations in the combined
sample, corresponding to 0.34 cm per allele copy. Two additional
loci, NPR3 and JAZF1, which were previously reported as weakly
associated to height (P-values.1025 [6]) reached GW-significance
in our study (rs10472828 in NPR3, P-value = 361027 and
rs849141 in JAZF1, P-value = 3.2610211, Table 1). The remain-
ing thirteen loci reaching GW-significance (Table 1) had been
described in one or more of the recent GWA scans for stature,
providing strong evidence for independent and widespread
replication [6–10]. The Weedon et al (2008) study shared
approximately 3,200 samples with our discovery cohort (EPIC
cohort). Six of the eight loci discovered in both studies reached
GW-significance in our replication set when EPIC was excluded
from the analysis (Table 1), indicating independent replication of
these loci in the remaining sample collections.
The strongest association signals in our combined set were
observed at HMGA2 (rs8756, P-value 5610214) and UQCC
Author Summary
The first genetic association studies of adult height have
confirmed a role of many common variants in influencing
human height, but to date, the genetic basis of differences
between different skeletal components of height have not
been addressed. Here, we take advantage of recent
technical and methodological advances to examine the
role of common genetic variants on both height and
skeletal components of height. By examining nearly 20,000
individuals from the UK and the Netherlands, we provide
statistically significant evidence that 17 genomic regions
are associated with height, including four novel regions.
We also examine, for the first time, the association of these
17 regions with skeletal size measurements of spine,
femur, and hip axis length, a measurement of hip
geometry known to influence the risk of osteoporotic
fractures. We find that some height loci are also associated
with these skeletal components, although further statisti-
cal tests will be required to verify if these genetic variants
act differentially on the individual skeletal measurements.
The knowledge generated by this and other studies will
not only inform the genetics of human quantitative
variation, but will also lead to the potential discovery of
many medically important polymorphisms.
Loci for Height and Skeletal Size
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(rs6088813, P-value 9.8610214) both of which have been
replicated in multiple studies [6–10]. The seventeen GW-
significant loci explain 0.07%–0.18% of total height variance in
our sample (Table 1). Finally, rs1812175 located in HHIP had a
nominal P-value in the replication sample but did not reach GW-
significance in the combined analysis (Table 1). A further six loci
which did not attain nominal significance in the replication sample
have suggestive evidence for association with height in the
combined sample (Table 1).
To assess heterogeneity in the height associations among
cohorts, we compared regression coefficients for height normalised
to z-scores using the Cochran’s and I2 statistics, finding little or no
evidence for heterogeneity (Table 1). We used a similar approach
to investigate gender-specific effects in height associations. We
focused on the Rotterdam study, which is the largest cohort with
similar numbers of males and females. We compared normalised
height z-scores calculated in 3,374 females and 2,362 males from
the Rotterdam Study using Cochran’s and I2 statistics (Table S3).
We observed limited evidence for gender-specific effects. The
exception was ADAMTS33 SNPs, where we detected significant
heterogeneity in height associations at all three SNPs investigated
(P-value = 0.002, I2 = 89%; Table S3).
Associations with Skeletal Size Measurements
We tested the association of the 17 GW-significant loci with
three different skeletal size measurements, namely spine length,
femur and hip axis length, which provide proxies for trunk, leg and
skeletal size length respectively.
We first investigated skeletal size measurements representing
proxies for trunk length. We analysed 6,053 samples from three
cohorts with available measurements of spine length (TwinsUK
and Chuvasha) and vertebral body heights (Rotterdam Study). We
combined study-specific summary statistics using z-scores and
found that nine of the 17 loci were significantly associated with
trunk length at the nominal level. The strongest associations with
spine were at rs6570507 in GPR126 (P-value = 461025),
rs6817306 in LCORL (P-value = 461024), rs849141 in JAZF1 (P-
value = 0.001) and rs10472828 in NPR3 (P-value = 0.0018)
(Table 2).
We next tested association of the 17 confirmed height loci with
hip axis length (HAL) in 2,341 individuals from the Rotterdam
Study (Table 3). HAL is a highly-heritable measure of femoral
geometry that measures the distance from the lateral aspect of the
greater trochanter to the inner border of the pelvic rim, passing
through the mid-section of the femoral neck. HAL is strongly
correlated with total frame size and height [11] and represents a
clinically important predictor of hip fracture independent of age
and femoral neck bone mineral density [12]. Of the 17 validated
height loci, seven had one or more SNPs significantly associated
with HAL in the Rotterdam Study, with the strongest statistical
associations observed at LCORL (rs6830062; P-value = 4.861024)
and UQCC (rs4911494; P-value = 1.961024).
Finally, we investigated associations of the 17 validated height
loci with measurements of lower limb length (femur) in 3,505
individuals from two cohorts (TwinsUK, N = 2,364 and Chuvasha,
N = 1,141). The strongest associations with femur length were
observed at rs710841 (PRKG2, P-value = 2.461025) and
rs10946808 (HIST1H1D, P-value = 6.461026) (Table S4).
Exploratory Conditional Analyses
We used the following qualitative approach to explore a possible
differential contribution of height loci to skeletal size measure-
ments. We selected a homogeneous set of measurements (vertebral
heights and HAL in the Rotterdam Study, and femur length in
TwinsUK) to avoid bias deriving from heterogeneous measure-
ments among cohorts. Although this is expected to reduce the
power to detect statistically significant associations, the magnitude
of the betas is unlikely to be materially affected. Secondly, we re-
calculated associations of the 17 GW-significant height loci with
each skeletal size measurement as described before, only in this
case we restricted the analysis to the homogeneous set of
measurements. We then performed an analysis where association
with each skeletal size measurement was assessed after adding
height as an additional term to the linear regression model. We
finally compared qualitatively the magnitude of the association,
expressed as regression coefficients and SE, in the two models
(univariate and height-adjusted). In cases where the locus acts
prevalently through the given skeletal size measurement, we expect
the regression coefficients of the height-adjusted analysis to show
the least reduction compared to the original unadjusted analysis.
For loci showing associations in the height-adjusted analysis, we
then recalculated associations with height after adding skeletal size
in the linear regression model. A null regression coefficient in this
case suggests that the height association may be explained by the
prevalent effect of the locus on the skeletal measurement under
exam. Collectively, these conditional analyses, with relevant
caveats [13], can provide some indicative information as to
whether the association between relevant genetic variants and
height may be mediated by specific components of height.
Spine. Table 2 shows that in most cases, the betas in the
height-adjusted model were either close to the null (e.g. the four
SNPs in DLEU7) or strongly reduced (e.g. for the SNPs in HLA-B).
The GPR126 locus (rs6570507 and rs12189801) displayed the least
reduction in regression coefficients between the two models
(Table 2). The regression coefficient of rs6570507 for the
reversed scenario (testing association with height after adjusting
for trunk size) was close to zero (20.019 (0.031), P-value = 0.55), a
result that may indicate that GRP126 variants may contribute to
height principally through trunk length elongation. LCORL
SNPsdisplayed a similar albeit less pronounced change in the
magnitude of the relevant beta coefficient, where a partial
reduction in the regression coefficients (from 0.162 (0.04) to
0.091 (0.04) for rs6830062) was observed after addition of height in
the model (Table 2).
Hip Axis Length. The results of these analyses are shown in
Table 3. The GNA12, HMGA2 and UQCC loci showed the smallest
attenuation in the magnitude of the regression coefficients in the
height-adjusted model. At the other extreme, the magnitudes of
beta coefficients at loci such as JAZF1 or HLA-B approached null
in the height-adjusted model.
Femur length. The least reduction in regression coefficients
was observed for SNPs in ADAMTSL3 (Table S4).
Expression Association Analysis
Observed association signals in intergenic regions may be due to
regulatory variants of nearby genes. For the 17 validated height
loci (Table 1) we undertook an eQTL analysis in 2 Mb windows
centered on each lead SNP (see Materials and Methods for details)
using expression data from lymphoblastoid cell lines derived from
individuals of the four HapMap population panels [14]. The
recombination interval harboring rs1182188 contains a total of 27
SNPs tested for association with both height and expression. We
tested 14 genes within 61 MB of this interval and found
significant expression association evidence (Spearman Rank
correlation P-value,0.001) for 2 of them (GNA12 and
LOC392620) in at least one HapMap population. The rankings
of the CEU expression and height association p-values at the 27
tested SNPs correlate well, suggesting a potential common
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functional variant underlying both the height and expression signal
(GNA12: rho = 0.678, P-value = 0.0001; LOC392620; rho = 0.386,
P-value = 0.047). Simulation of random significant eQTLs at this
interval (as significant as the observed ones, maintaining SNP
frequencies and haplotype structure) and comparison of the
height-expression correlation strength to the observed data
indicates that the probability of obtaining such a relationship
between the two phenotypes by chance is very small (P-
value = 0.0228). We detected one cis signal that reached
significance in the eQTL analysis in a 340 Kb region of
chromosome 7 centred on rs1182188. The rs1182188 SNP is
located in the first intron of GNA12 (Figure 1). GNA12 encodes for
Galpha12, a serine/threonine phosphatase modulating essential
signalling pathways, including apoptosis [15,16], regulation of the
actin cytoskeleton and cadherin-mediated cell-cell adhesion
[17,18]. Even though it is known that apoptosis and cadherin-
mediated signalling are involved with oncogenic effects during
tumor progression, we have no clear indication how they can
contribute to the determination of body height.
Discussion
We carried out a genome-wide scan for stature in 12,611 adults
of Caucasian origin and identified seventeen independent regions
Table 2. Association of validated height loci with trunk length.
SNP Locus A1/A2 All Samples (n=6,053) Rotterdam Study
Univariate Height-adjusted
Zscore P-value % variance Beta (SE) P-value Beta (SE) P-value
rs11809207 CATSPER4 A/G 1.867 0.062 0.049 0.069 (0.036) 0.054 0.024 (0.036) 0.507
rs6763931 ZBTB38 A/G 2.129 0.033 0.031 0.019 (0.028) 0.49 20.017 (0.028) 0.540
rs6854334 LCORL T/C 1.648 0.099 0.100 0.118 (0.042) 0.005 0.061 (0.042) 0.142
rs6817306 LCORL T/C 3.54 461024 0.165 0.150 (0.042) 3.761024 0.094 (0.042) 0.026
rs6830062 LCORL T/C 2.86 0.004 0.212 0.162 (0.040) 5.861025 0.091 (0.040) 0.024
rs710841 PRKG2 T/C 1.098 0.272 0.033 0.024 (0.032) 0.453 0.020 (0.032) 0.536
rs2011962 PRKG2 A/C 20.921 0.357 0.013 20.032 (0.032) 0.312 20.008 (0.032) 0.794
rs10472828 NPR3 T/C 23.121 0.002 0.117 20.068 (0.028) 0.016 20.026 (0.028) 0.366
rs10946808 HIST1H1D A/G 2.657 0.008 0.111 0.007 (0.031) 0.811 20.064 (0.031) 0.036
rs9358913 HIST1H4F A/G 2.559 0.010 0.089 0.003 (0.031) 0.924 20.057 (0.031) 0.065
rs13437082 HLA-B T/C 22.138 0.033 0.060 20.063 (0.032) 0.052 0.011 (0.032) 0.727
rs4711269 HLA-B T/C 22.065 0.039 0.059 20.064 (0.032) 0.047 0.011 (0.032) 0.735
rs7742369 HMGA1/C6orf106 A/G 21.357 0.175 0.016 20.039 (0.036) 0.278 20.009 (0.036) 0.808
rs1776897 HMGA1/C6orf106 T/G 22.807 0.005 0.033 20.077 (0.048) 0.105 20.043 (0.048) 0.373
rs2814993 HMGA1/C6orf106 A/G 0.923 0.356 0.013 0.050 (0.040) 0.206 20.004 (0.040) 0.923
rs12189801 GPR126 T/C 2.841 0.005 0.103 0.082 (0.039) 0.038 0.076 (0.039) 0.052
rs6570507 GPR126 A/G 24.109 461025 0.220 20.089 (0.031) 0.004 20.058 (0.031) 0.062
rs1182188 GNA12 T/C 1.61 0.107 0.041 0.022 (0.032) 0.487 0.023 (0.032) 0.465
rs1182179 GNA12 A/G 0.502 0.615 0.036 0.021 (0.032) 0.509 0.022 (0.032) 0.486
rs849141 JAZF1 A/G 3.252 0.001 0.097 0.087 (0.030) 0.005 0.021 (0.031) 0.486
rs2282978 CDK6 T/C 21.625 0.104 0.007 20.014 (0.029) 0.637 0.012 (0.029) 0.694
rs1480474 HMGA2 A/G 1.479 0.139 0.043 0.052 (0.029) 0.070 0.003 (0.029) 0.923
rs8756 HMGA2 A/C 21.484 0.138 0.033 20.046 (0.028) 0.105 0.015 (0.028) 0.603
rs3118912 DLEU7 T/C 21.505 0.132 0.101 20.101 (0.035) 0.004 20.007 (0.035) 0.835
rs3118914 DLEU7 T/G 21.255 0.209 0.104 20.103 (0.035) 0.003 20.009 (0.035) 0.789
rs3116607 DLEU7 A/C 22.19 0.029 0.099 20.104 (0.037) 0.005 20.0005 (0.037) 0.990
rs3118916 DLEU7 A/G 22.443 0.015 0.073 20.088 (0.036) 0.014 20.005 (0.036) 0.892
rs910316 TMED10 A/C 20.028 0.978 0.031 0.030 (0.028) 0.287 20.009 (0.028) 0.765
rs2401171 ADAMTSL3 T/G 0.251 0.802 0.005 20.00003 (0.028) 0.999 0.032 (0.028) 0.252
rs7183263 ADAMTSL3 T/G 20.98 0.327 0.010 0.014 (0.028) 0.615 0.050 (0.028) 0.074
rs4842838 ADAMTSL3 T/G 1.248 0.212 0.005 20.014 (0.028) 0.615 20.050 (0.028) 0.074
rs4911494 UQCC T/C 21.761 0.078 0.061 20.048 (0.029) 0.097 20.021 (0.029) 0.477
rs6088813 UQCC A/C 21.561 0.118 0.055 20.047 (0.029) 0.106 20.020 (0.029) 0.494
For each locus, the meta-analysis P-value was calculated for best analysis of all cohorts with available trunk size data, namely length of spine measurements in TwinsUK
and Chuvasha and sum of vertebral heights in the Rotterdam Study. Univariate and conditional analyses were carried out on a subset of 2,536 individuals of the
Rotterdam Study with available vertebral height and height data.
doi:10.1371/journal.pgen.1000445.t002
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having GW-significant associations at the 561027 threshold [19],
and seven additional loci with suggestive evidence for association
(P-values between 561027 and 1025). Two of the regions with
GW-significant associations with stature are novel and were
centred on an intronic SNP in CATSPER4 (rs11809207, combined
P-value = 6.161028), and on the first intron of TMED10
(rs910316, P-value = 1.461027). CATSPER4 encodes for a recep-
tor membrane ligand ion channel with a role in acrosome reaction
and male fertility [20], whereas TMED10 (TMP21) encodes for a
presenilin complex component with a role in vesicular protein
trafficking [21]. Both these functions do not have an obvious
association with height, which may be mediated by variants in
nearby genes. For instance, the lead SNP in TMED10 is in high
linkage disequilibrium with three SNPs in NEK9 displaying
marginally lower association P-values in the genome-wide scan.
NEK9 is a regulator of cellular processes essential for interphase
progression [22], a biological function shown to be overrepresent-
ed among height association signals [6].
We also identified two additional loci showing genome-wide
statistical association with height, namely rs10472828 in NPR3 (P-
value = 361027) and rs849141 in JAZF1 (P-value = 3.2610211)
both of which were identified with low confidence (P-value.1025)
in one recent GWA scan also using Illumina genome chips [6].
NPR3 encodes for natriuretic peptide (NCP), a protein class that
elicit a number of vascular, renal, and endocrine effects that are
important in the maintenance of blood pressure and extracellular
fluid volume [23]. JAZF1 is a transcriptional repressor associated
with a role in endometrial stromal tumors [24]. Interestingly,
Table 3. Association of validated height loci with hip axis length (HAL).
SNP Locus A1/A2 Univariate Height-adjusted
% variance BETA (SE) P-value BETA (SE) P-value
rs11809207 CATSPER4 A/G 0.003 20.011 (0.038) 0.778 20.051 (0.037) 0.174
rs6763931 ZBTB38 A/G 0.21 0.065 (0.029) 0.025 0.025 (0.029) 0.393
rs6854334 LCORL T/C 0.31 0.118 (0.044) 0.007 0.056 (0.044) 0.195
rs6817306 LCORL T/C 0.32 0.121 (0.044) 0.006 0.054 (0.044) 0.220
rs6830062 LCORL T/C 0.52 0.145 (0.042) 4.861024 0.078 (0.042) 0.062
rs710841 PRKG2 T/C 0.02 0.022 (0.034) 0.518 20.010 (0.034) 0.765
rs2011962 PRKG2 A/C 0.07 20.042 (0.033) 0.206 20.008 (0.033) 0.819
rs10472828 NPR3 T/C 0.09 20.043 (0.030) 0.149 20.007 (0.030) 0.802
rs10946808 HIST1H1D A/G 0.02 0.020 (0.032) 0.532 20.015 (0.032) 0.645
rs9358913 HIST1H4F A/G 0.02 0.022 (0.032) 0.492 20.003 (0.032) 0.927
rs13437082 HLA-B T/C 0.06 20.042 (0.035) 0.226 20.004 (0.035) 0.912
rs4711269 HLA-B T/C 0.09 20.050 (0.034) 0.146 20.013 (0.034) 0.709
rs7742369 HMGA1/C6orf106 A/G 0.17 20.074 (0.037) 0.048 20.050 (0.037) 0.178
rs1776897 HMGA1/C6orf106 T/G 0.09 20.072 (0.050) 0.151 0.014 (0.050) 0.776
rs2814993 HMGA1/C6orf106 A/G 0.004 20.012 (0.040) 0.773 20.047 (0.040) 0.236
rs12189801 GPR126 T/C 0.003 0.011 (0.042) 0.793 20.039 (0.042) 0.353
rs6570507 GPR126 A/G 0.07 20.043 (0.032) 0.187 0.013 (0.032) 0.689
rs1182188 GNA12 T/C 0.30 0.086 (0.032) 0.008 0.080 (0.032) 0.013
rs1182179 GNA12 A/G 0.31 0.087 (0.032) 0.007 0.082 (0.032) 0.011
rs849141 JAZF1 A/G 0.14 0.057 (0.032) 0.072 0.008 (0.032) 0.792
rs2282978 CDK6 T/C 0.15 20.057 (0.031) 0.062 20.040 (0.031) 0.194
rs1480474 HMGA2 A/G 0.26 0.074 (0.030) 0.014 0.037 (0.030) 0.214
rs8756 HMGA2 A/C 0.42 20.092 (0.029) 0.002 20.061 (0.029) 0.039
rs3118912 DLEU7 T/C 0.43 20.117 (0.037) 0.002 20.022 (0.037) 0.562
rs3118914 DLEU7 T/G 0.42 20.115 (0.037) 0.002 20.020 (0.037) 0.596
rs3116607 DLEU7 A/C 0.16 20.076 (0.040) 0.055 0.030 (0.040) 0.447
rs3118916 DLEU7 A/G 0.28 20.098 (0.038) 0.01 20.015 (0.038) 0.693
rs910316 TMED10 A/C 0.001 0.005 (0.030) 0.865 20.050 (0.030) 0.090
rs2401171 ADAMTSL3 T/G 0.15 20.055 (0.029) 0.057 20.033 (0.029) 0.254
rs7183263 ADAMTSL3 T/G 0.21 20.065 (0.029) 0.027 20.044 (0.029) 0.132
rs4842838 ADAMTSL3 T/G 0.21 0.065 (0.029) 0.027 0.044 (0.029) 0.132
rs4911494 UQCC T/C 0.59 20.112 (0.030) 1.961024 20.093 (0.030) 0.002
rs6088813 UQCC A/C 0.57 20.110 (0.030) 2.561024 20.091 (0.030) 0.002
Association of height loci with HAL in the Rotterdam Study (n = 2,341). Associations were calculated on age- and gender-adjusted (univariate) or age-, gender- and
height-adjusted (height-adjusted) standardised residuals.
doi:10.1371/journal.pgen.1000445.t003
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common variants in JAZF1 were also recently implicated in type 2
diabetes and prostate cancer susceptibility [25,26], in line with
evidence for pleiotropic effects at many common disease loci. The
remaining thirteen loci were previously described [6–10],
confirming highly reproducible height associations despite overall
small effect sizes for individual loci. Our study confirmed HMGA2
(rs8756, P-value 5610214) and UQCC (rs6088813, P-value
9.8610214) as the loci with the strongest overall association with
height [6–10].
In this study we also attempted, for the first time, to study the
contribution of height loci to the components of trunk and leg length
using measurements of skeletal size by directly testing associations of
the 17 validated height regions with skeletal size parameters of
trunk, leg and skeletal frame size, and by conducting an exploratory
conditional analysis. Some intrinsic limitations of our study design
and analytical approaches need to be taken into consideration in the
interpretation of results for skeletal size measurements.
Firstly, although we assembled the largest dataset of this kind,
the small sample size available for skeletal size associations will
have affected our ability to conclusively confirm or rule out
associations for some loci. However, the composite nature of
height as a phenotype, and an overall higher accuracy and
specificity of the skeletal measurements in assessing the contribu-
tion of genetic loci to limb length, suggests that smaller sample
sizes might be sufficient to detect associations for these
intermediate traits with high confidence. For example, the
seventeen GW-significant height loci jointly explain approximately
5% of total variance in femur length, which is more than twice the
variance in height explained by the same loci combined.
In order to increase power, we combined trunk size measure-
ments from different cohorts that, despite being highly correlated,
were not identical. Radiographic measurements of vertebral height
size (Rotterdam Study) provide a more accurate measure of the
skeletal component of trunk height compared to the DXA-derived
Figure 1. Association with gene expression in the GNA12 region. (A) P-values, expressed on the 2log10 scale, for associations with adult
height (red) and gene expression measured at probes specific for GNA12 (blue) and LOC392620 (magenta) within the 370-Kb recombination interval
surrounding the lead SNP rs1182188. (B) Association signal with height in the 1 MB interval surrounding the lead SNP. The red dot indicates the
association P-value for the lead SNP rs1182188 in the discovery GWAS+EPIC sample (n = 12,611 individuals), the blue dot indicates the meta-analysis
P-value after replication. Red diamonds indicate high LD with the lead SNP (r2.0.8), orange diamonds indicate moderate LD with the lead SNP
(0.5,r2,0.8), yellow indicates markers in weak LD with the lead SNP (0.2,r2,0.5), white indicates either no LD with the lead SNP (r2,0.2), or loci
where such information was not available.
doi:10.1371/journal.pgen.1000445.g001
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measurements of the total spine (TwinsUK and Chuvasha), which
include inter-vertebral disk heights and potential measurement
error due to vertebral crush fractures. Measuring skeletal
associations requires methods that are relatively expensive and
low-throughput compared to height, making it difficult to assemble
large homogeneous samples for analysis. To provide more
comparable estimates of association, we focused our analyses on
a subset of homogeneous standardised measurements of vertebral
size and HAL in the largest available cohort, the Rotterdam
Study.
To help assess whether components of skeletal height mediated
the association between relevant genetic loci and height, and to
examine the independency of associations between genetic loci
and components of height, we conducted an exploratory
conditional analysis. In this and related contexts, conditional
analysis to infer conditional independence and mediation has
limitations. Conditional analysis of highly correlated traits (for
example, height and skeletal subcomponents of height) can lead to
an attenuation of effect sizes for relevant genetic loci even when
there is no underlying causal network between genetic variants
and mediating traits [13]. These analyses also assume that
measurement error is evenly distributed among traits. Differences
in measurement error among traits can result in spurious
inferences - distorting the magnitude of relevant effect sizes in
conditional and unconditional analyses. The latter is also relevant
to conditional analyses of genetic variants. Moreover, because of
the statistical resolution required to assess differences in uncon-
ditional and conditional analyses, and the correlated variance
structures of these data (testing differences in effect estimates using
the same sample population) we opted to use a qualitative
assessment of these interrelated associations rather than a
quantitative one.
With the above caveats in mind, our results provide some
interesting first insights into the potential contribution of height
loci and possible differential effects on skeletal size measurements.
These results should be considered exploratory and will require
replication in larger cohorts to better understand their role and
address potential sources of heterogeneity including the impact of
measurement error. For instance, in a previous study Weedon and
colleagues [10] described an association for HMGA2 (rs1042725)
with sitting height (0.2 cm increase for the C allele, 95% C.I. 0.1–
0.3, P-value = 0.0002) in a cohort of approximately 2,000 children.
Although this may suggest a differential effect on trunk length, in
our study such association was not replicated in an adult sample of
6,509 individuals for a highly correlated SNP in the same locus
(rs8756, r2 = 0.87 in CEU, combined P-value = 0.12). Yet, direct
spine length measures in adults are likely to be more precise and
specific than measures of sitting height since they are less affected
by sources of measurement error that may explain such discordant
results. For instance, sitting height is prone to measurement errors
affected by head dimensions which are disproportionate in
children (having already achieved adult head dimensions around
3 years of age, long before the pubertal growth spurt). In addition,
radiographic measures of spine length will also be less affected by
other artefacts arising from posture differences, age-specific growth
patterns and/or possible common age-related effects of inter-
vertebral disk degeneration, all of which can play a key role in this
discrepancy.
The clinical relevance of the effects observed for these height
loci is interesting and merits further exploration. Several loci
displayed significant association with HAL, a measurement shown
to vary between ethnic groups and to have substantial heritability.
In addition HAL is highly correlated with long limb growth and
represents an important predictor for osteoporotic fracture [12]. In
our study, two intronic variants in the recombination interval
containing GDF5 and UQCC (rs4911494 and rs6088813) were
strongly associated with HAL in the Rotterdam study (P-
values = 161024 and 1.3261024 respectively), but not with femur
length (P-values = 0.83 and 0.76 respectively). GDF5 is a member
of the TGF-beta superfamily of growth factors/signalling mole-
cules that act as regulators of cell growth and differentiation in
both embryonic and adult tissues. Mutations in this gene are
associated with severe skeletal malformations including acrome-
somelic dysplasia, Hunter-Thompson type, brachydactyly, type C
and chondrodysplasia Grebe type [27–29]. A common functional
SNP in the 59 UTR of GDF5 (+104T/C; rs143383) has been
associated with osteoarthritis (OA), the commonest form of human
arthritis characterized by degeneration of articular cartilage and
bone remodelling [30,31]. OA is also under strong genetic
influence, with several shared genetic risk factors with skeletal
traits including bone density, bone content, turnover and skeletal
alignment [32]. The two low-stature alleles rs4911494-A and
rs6088813-A were in high linkage disequilibrium with the risk T
allele at rs143383 (r2 = 0.93), indicating a possible role of this gene
in cartilage metabolism and/or bone shape and alignment in
determining height.
In summary, this study extended by four the list of loci with
confirmed association to adult height, which now comprises 47
independent regions. The use of fine mapping through genotype
imputation and resequencing will be important for refining the
association signal in each locus and for identifying the true
causative variants. The potential differential effects that we
observed of height loci to lower limb and trunk growth are
consistent with some genes potentially acting as regulators of long-
bone growth, while others appear to be specific to different bone
sites or to influence cartilage growth. Further analytical and
experimental approaches to assess the contribution of height loci
to skeletal measurements and intermediate phenotypes will be
important to understand the physiology of human growth, and
may lead to the identification of genetic variants relevant to diverse
musculoskeletal pathologies in humans.
Note: While this manuscript was in review the JAZF1 locus was
confirmed by an independent study [33].
Materials and Methods
Gwas Study Design
The initial discovery sample included 9,400 samples of European
origin, including 1,430 British individuals (710 females and 720
males) from the British 1958 Birth Cohort, 2,224 individuals from
the TwinsUK cohort (all females) and 5,746 individuals (3,374
females and 2,372 males) from a Dutch cohort (Rotterdam Study).
After applying quality filters, 299,216 SNPs remained for analysis
with data in at least 9,000 individuals. Further details of individual
cohorts are given below and in Table S1. In addition to these three
cohorts we also had available GWAS data for 3,211 samples from
the EPIC Norfolk study, genotyped using the Illumina Human-
Hap300 (v1) SNP panel. These individuals were genotyped using
the Affymetrix 500 K SNP panel in a recent height meta-analysis
[9], and therefore do not constitute an independent discovery
sample. Nevertheless, as the samples may provide novel loci once
combined with different cohorts and a different platform, we
included them in a second stage of discovery. Furthermore, these
samples provide independent replication for published height
signals, except than for those described in the Weedon scan [9]
(Table 1). For this reason in Table 1 we provided association
statistics both including and excluding the EPIC collection for all
loci already described by Weedon and colleagues.
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Population Samples and Genotyping
TwinsUK (KCL) - discovery sample. Sample: the
TwinsUK cohort (KCL, www.twinsuk.ac.uk) is an adult twin
British registry shown to be representative of singleton populations
and the United Kingdom population [34]. A total of 2,224 females
with height phenotype were included in the discovery cohort,
including 1,018 singleton individuals (754 from a MZ pair and 253
from a DZ pair and 11 of unknown zygosity) and 1,206 siblings
from 603 DZ twin pairs. In order to increase power in the height
analysis, we increased the sample size by considering in the
analysis siblings of monozygotic twin pairs not genotyped in the
GWAS. Briefly, for each MZ pair where genotype data was
available (n = 754), we set the genotype data of the un-genotyped
sibling to be identical to that of the genotyped twin. The
phenotype was the observed phenotype for the un-genotyped
twin. Corrections for sample relatedness (MZ and DZ status) using
variance components were incorporated in the subsequent
statistical analysis as explained in the Statistical Analysis section.
The mean age of the TwinsUK cohort was 46.6 years (range 16–
84). Ethics approval was obtained from the Guy’s and St. Thomas’
Hospital Ethics Committee. Written informed consent was
obtained from every participant to the study.
Height and skeletal measurements: Standing height (cm) was
measured as described in [35]. Length of spine (C4 to L4) and
femur (greater trochanter to medial condyle) were taken on
TwinsUK subjects (age 18–80 years) using linear pixel count (LPC)
on whole body dual energy x-ray absorptiometry (DXA) imaging.
LPC uses the regions of interest (ROI) sub-regional analysis mode
on a Hologic QDR-4500W DXA scanner (Hologic Inc., Bedford,
MA) to determine lengths of bones and has proven to be a valid
and reproducible method of measuring DXA lengths with a
coefficient of variation (CV%) of 1.6% [36]. Femur and spine
length were strongly correlated with height (r = 0.82 and 0.59,
Table S1).
Genotyping: All samples were typed with Infinium assays
(Illumina, San Diego, USA) as described in Richards et al. [34].
For TwinsUK, we pooled together the normalised intensity data
[37] for 2,820 Twins UK samples typed at the Duke University
Genotyping Center (NC USA), Helsinki University (Finland) and
the Wellcome Trust Sanger Institute. We used the Illluminus
calling algorithm [38] to assign genotypes in the pooled data. No
calls were assigned if an individual’s most likely genotyped was
called with less than a posterior probability threshold of 0.95.
Validation of pooling was achieved via a visual inspection of 100
random, shared SNPs for overt batch effects. None were observed.
Finally, intensity cluster plots of significant SNPs were visually
inspected for over-dispersion biased no calling, and/or erroneous
genotype assignment. SNPs exhibiting any of these characteristics
were discarded. We excluded subjects based on the genotype data
when (i) SNP call rate was,95%, (ii) heterozygosity was.37% or
,33% across all SNPs, (iii) there was evidence of non-European
ancestry. We corrected misclassified monozygotic and dizygotic
twins based on concordance rates. At the SNP level, the QC filters
applied were Hardy-Weinberg p-value$1026 (1,555 SNPs
removed); MAF$5% (9,489 SNPs removed); SNP call rate
$95% (777 SNPs removed); 307,040 SNPs were retained for
analysis.
The Rotterdam Study (RS) - discovery sample. Sample:
Samples in this cohort were derived from the Rotterdam Study
(n = 7,983), a single-center prospective population-based study of
determinants of chronic disabling diseases in elderly individuals
(age 55 years and over) [39,40]. DNAs from 5,746 individuals with
height information (3,374 females and 2,372 males) were
genotyped using the Illumina HumanHap 550 K SNP array as
part of a large population based project on genetics of complex
traits and diseases financed by the Dutch government through the
Netherlands Scientific Organization - Large Investments (NWO
Groot; 175.010.2005.011). The mean age of the samples analysed
was 68.3 years (range 55–99). Written informed consent was
obtained from every participant and the study was approved by
the Institutional Ethics Review Committee.
Height and skeletal measurements: Standing height (cm)
measurements were attained by a trained research assistant at
the baseline visit using a standard wall-mounted statiometer.
Thoracolumbar spine lengths (cm) extending from T7 to L4 were
calculated by summing the mean of anterior, medial and posterior
vertebral heights assessed radiographically in 2550 genotyped
subjects after a mean follow-up of 6.460.4(SD) years. X-rays were
scored for the presence of vertebral fractures using the MCClos-
key/Kanis method [41] and only individuals without incident or
prevalent vertebral fractures were included in the analysis. HAL
measurements [12] were obtained from DXA femoral scans
performed after a mean follow-up of 11.160.6 (SD) years using a
ProdigyTM fan-beam densitometer (GE-LUNAR corporation
Madison, WI). Body height at baseline was strongly correlated
with both follow-up measurements of spine length r = 0.78 and
HAL r = 0.79.
Genotyping: Genotyping of the samples from the Rotterdam
study was carried out at the Genetic Laboratory of the
Department of Internal Medicine of Erasmus MC, Rotterdam,
The Netherlands using the HumanHap500 V.3 Illumina SNP
Array. The Beadstudio GenCall algorithm was used for data
calling an quality control (QC) procedures were performed as
described earlier [34]. For this study QC filters were applied to the
316,334 SNPs overlapping with the HumanHap300 set, and
included Hardy-Weinberg p-value$1026 (2,229 SNPs removed);
MAF$5% (9,056 SNPs removed); SNP call rate $95% (4,135
SNPs removed); 306,942 SNPs overlapping with the TwinsUK
and 1958 Birth Cohort data were retained for analysis.
1958 Birth Cohort (58BC) - discovery sample. Sample:
The British 1958 Birth Cohort is a national population sample of
individuals born within a single week in 1958, and followed
periodically from birth to age 44–45 years, when a DNA bank was
established as a national reference series for case-control studies.
The samples selected for genotyping correspond to 1502 cohort
members included as population controls in the Wellcome Trust
Case-Control Consortium [39]. After quality control checks for
contamination, non-Caucasian identity, relatedness and low call
rate (,93%), 1430 individuals (710 females and 720 males) were
available with whole-genome data and were included in the meta-
analysis (http://www.b58cgene.sgul.ac.uk/).
Height measurements: Standing height was measured in the
home, and adjusted throughout for instrument and survey nurse
(which also adjusts for any geographical variations). Z-scores were
calculated on untransformed height data (cm), standardising
height by gender. Field protocols, informed consent and this
within-cohort genetic association analysis were approved by the
South East NHS Multi-Centre Research Ethics Committee.
Genotyping: Genomic DNAs from 1958 Birth Cohort samples
were genotyped at WTSI using the HumanHap500 Illumina
array. Genotypes were called using the GenCall algorithm and
two rounds of manual curation. The same QC filters were applied
to the SNPs overlapping with HumanHap300 chip. Hardy-
Weinberg p-value$1026 (404 SNPs removed); MAF$5% (8,404
SNPs removed); SNP call rate $95% (10,002 SNPs removed);
309,549 SNPs were retained for analysis.
EPIC Norfolk - discovery sample. Sample: The European
Prospective Investigation into Cancer and Nutrition study (EPIC-
Loci for Height and Skeletal Size
PLoS Genetics | www.plosgenetics.org 10 April 2009 | Volume 5 | Issue 4 | e1000445
Norfolk) is a prospective population study of 25,663 men and
women aged between 40 and 79 years, resident in Norfolk, UK.
Participants are recruited from general practice registers between
1993 and 1997 and represent an ethnically homogeneous
Caucasian population. Details of recruitment, anthropometric
measurements, and health examinations following standardized
protocols have been published [42]. All participants gave signed
informed consent and The Norwich District Health Authority
Ethics Committee approved the study. The EPIC Obesity cohort
analysed here has been described elsewhere [43] and includes a
total of 3,211 participants randomly selected from the EPIC
Norfolk Study. We analysed 2,117 samples from the general EPIC
cohort distribution (mean age 59 years, range 39–77), and an
additional set of 1,094 cases randomly selected from the obese
individuals within this cohort as having a BMI$30 (mean age 59.4
years, range 39–76).
Height measurements: Height and weight were measured using
standard anthropometric techniques. Height z-scores were calcu-
lated by standardising untransformed height by gender and age
decades. The Norwich Local Research Ethics Committee granted
ethical approval for the study. All participants gave written
informed consent.
Genotyping: The EPIC samples were genotyped at WTSI on
whole-genome amplified DNA. Genotype data calling of the EPIC
cohort was carried using the Illuminus algorithm. Prior to analysis
the SNPs were subject to the QC criteria used before: Hardy-
Weinberg p-value$1026 (4,915 SNPs removed); MAF$5%
(11,331 SNPs removed); SNP call rate $95% (8,682 SNPs
removed); 295,512 SNPs were retained for analysis.
TwinsUK - replication sample. Sample: An additional
2,294 samples (all females) from the TwinsUK cohort described
previously were genotyped as part of the replication set. 174
individuals were siblings (DZ twins) of individuals genotyped in the
discovery cohort. Height and skeletal measurements were obtained
as described previously.
The Chingford Study - replication sample. Sample: The
Chingford Study is a prospective population-based longitudinal
cohort. The Chingford study includes 1,003 women derived from
the age/sex register of a large general practice in North London,
who are representative of the general UK population in terms of
weight, height and smoking characteristics [44]. The study design
and rationale are described elsewhere in detail [45,46]. The
women were recruited from 1987–1989 and were seen annually
for radiographs and clinical examination. All subjects completed a
standardized questionnaire on medical history. The Guys&St
Thomas’ Trust and Waltham Forest Trust ethics committees
approved the study protocol.
Height measurements: Height measurements were obtained
using standard anthropometric techniques.
Chuvasha - replication sample. Sample: Chuvashians are a
Caucasian Finno-Ugric speaking population residing in the
Chuvasha and Bashkortostan autonomous regions of the Russian
Federation [47]. The individuals included in the study were
screened for known bone diseases and risk factors for increased
bone loss (such as diabetes and hyperparathyroidism) and were
naı¨ve to common medications such as hormone replacement
therapy and steroid medication. Each subject signed a written
consent form containing information about the study. The study
was approved by the Helsinki Ethics Committee of Tel-Aviv
University, Tel Aviv, Israel.
Height and skeletal measurements: Body length was measured
using a statiometer and steel rulers (with 1 mm gradations)
following standard anthropometric techniques [48]. Vertebral
column length (spine) was calculated as the difference between
suprasternal height and lower limb length, thus excluding the
cervical region. Femoral length was calculated as the difference
between the lower limb length and tibial height. Femur and spine
length were strongly correlated with height (r = 0.83 and 0.68,
Table S1).
Cambridge BioResource (CBR) - replication
sample. Sample: The Cambridge BioResource is a collection
of 4,000 pseudo-anonymised DNA samples. The collection of
DNA samples from 4,000 healthy blood donors has been
established by the Cambridge Biomedical Research Centre in
collaboration with NHS Blood and Transplant for use in
genotype-phenotype association studies.
Height measurements: Information on height (cm) self-declared
and obtained by questionnaire was available for 1,912 individuals.
Replication Genotyping
Genotyping of SNPs selected for replication was carried out
using mass spectrometry (Sequenom iPLEX) at the Wellcome
Trust Sanger Institute following standard procedures. Details of
genotyping assays are available upon request from the authors.
Statistical Methods
GW-association and stage-two analyses. Associations with
z-scores for the EPIC, Rotterdam and 1958 Birth Cohort were
tested using a generalised linear model (1df) assuming an additive
effect for the presence of each additional minor allele. Analyses were
carried out using the PLINK software package [49] (EPIC Norfolk
and Rotterdam Study) or Stata v.8.1. (College Station, TX, USA)
(BC58). GW-association analysis in the TwinsUK sample was
carried out using a score test and variance components to account
for twin status, implemented in the Merlin software package [50].
Meta-analyses. GW-meta-analysis statistics for height and
skeletal size were obtained using a weighted z-statistics method,
where weights were proportional to the square root of the number
of individuals examined in each sample and selected such as the
squared weights sum to be 1 [51]. Calculations were implemented
in the METAL package (http://www.sph.umich.edu/csg/
abecasis/Metal/). In the case of related samples the effective
sample size may inflate slightly the summary statistics, although by
simulation this effect has been shown to be negligible. Rather than
assigning an arbitrary effect size to the sample, the true sample
sizes were used for calculation.
Individual level analyses and quantile-quantile plots. All
individual-level analyses were implemented in the R statistical
package (www.r-project.org) or in StatsDirect. Quantile-quantile
plots were produced in R using custom scripts based on the
SNPassoc package [52].
Population stratification. We determined possible bias
arising from population substructure by assessing for population
stratification, excluding those individuals who were not of European
ancestry, and by applying genomic control. For TwinsUK,
stratification revealed three outliers that were removed as detailed
in Richards et al. [34]. For EPIC Norfolk, we removed four outliers.
There was no evidence of such effects after such exclusions, with
genomic inflation factors for all four studies #1.02. Details of
stratification of the 1958 Birth Cohort are available elsewhere [53].
Association with skeletal measurements. Association
with skeletal measurements was tested on untransformed bone
length after correcting for age (TwinsUK) and gender (Chuvasha),
or analyzing sex-stratified standardized residuals adjusted for age
(Rotterdam study). Associations in the TwinsUK set were tested on
the combined sample of GWAS and replication genotypes, for all
samples with skeletal measurements available (n = 2,375). Analyses
were carried out using a score test implemented in the Merlin
Loci for Height and Skeletal Size
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software. Associations in the Chuvasha sample were tested using
pedigree disequilibrium test (PDT) [54]. Associations in the
Rotterdam Study sample were tested using likelihood ratio and
Wald tests as implemented in the PLINK software [49].
Calculation of effect sizes. For calculation of effect sizes for
height, in order to obtain comparable estimates across all cohorts
we converted height data from the family-based and twin cohorts
to z-scores corrected by age and gender in a subset of unrelated
individuals (n = 1,381 for the discovery set, n = 1,403 for the
replication set). We then combined the summary statistics (beta
and standard deviation) using inverse-variance meta-analysis and
calculated the average effect size by multiplying the betas and
standard errors by the average height standard deviation in our
sample (6.43 cm in the combined dataset and 6.21 and 6.71 in
females and males respectively).
For skeletal size measurements, we note that individual cohorts
were measured using slightly different (albeit correlated) metrics
for spine (total length of spine in TwinsUK and Chuvasha, and
vertebral heights in the Rotterdam Study) and lower limb (femur
in TwinsUK and Chuvasha, and HAL in the Rotterdam Study.
To account for these differences we opted to carry out quantitative
tests of heterogeneity only on one study. For trunk length, we
focused on the Rotterdam study because (i) it was the largest of the
three cohorts, and thus likely the best powered; (ii) the vertebral
size measurements available for this cohort are a better proxy of
trunk length, as they are not affected by vertebral fractures and
intervertebral disk degradation; (iii) this cohort, unlike TwinsUK,
contains similar numbers of males and females. For femur we used
the TwinsUK collection, which represents the largest collection
with available data.
eQTL analysis. We carried out cis-association analysis for all
the 17 height signals with meta-analysis P-values,561027 as
follows. We retrieved gene expression data measured in
lymphoblastoid cell lines derived from the HapMap II
individuals as detailed in [14]. All genotyped HapMap II SNPs
in recombination hotspot intervals containing the 17 best hits were
interrogated for expression associations with genes within a
61 MB window, using Spearman Rank correlation (SRC).
Genes with at least one potential significant eQTL (SRC p-
value,0.001) were further considered. Out of the total number of
342 genes that met the 61 MB distance cutoff, we detected such
significant associations with 45 genes in at least one HapMap
population. For each of these genes, we then compared the
rankings of the expression and height association p-values at all
tested SNPs in the same hotspot interval using SRC.
In cases where the P-value rankings correlated well in the
observed data (rho.0 and p-value,0.05), we evaluated the
significance of the correlation in the CEU population by
simulating random significant eQTLs. Expression values of each
gene were shuffled 100,000 times and SNP associations recom-
puted. We considered a randomized interval significant if it
contained at least one association with a smaller p-value than the
most significant observed eQTL for that interval. For every
significant randomized interval, the comparisons of the rankings of
the shuffled expression and height associations were also
recalculated. Significance was assigned by comparing the
correlation coefficients at the significant randomized intervals
with the initial observed values. After simulations and comparisons
with the observed data, we identified one region with significant
evidence for cis-effects.
Web Resources
TwinsUK Cohort: http://www.twinsuk.ac.uk/
Chingford Cohort: http://www.chingfordstudy.org.uk/
1958 Birth Cohort: http://www.b58cgene.sgul.ac.uk/
Rotterdam Study: http://www.epib.nl/ergo.htm
R statistical package: http://www.r-project.org
METAL: http://www.sph.umich.edu/csg/abecasis/Metal/
Supporting Information
Figure S1 Quantile-Quantile plots for association with height,
calculated for (top row) the combined sample of males and females
and for (medium row) females and (bottom row) males alone, with
step-wise addition of additional cohorts (left to right): (i) TwinsUK;
(ii) Rotterdam Study; (iii) 1958 Birth Cohort; (iv) EPIC Norfolk
(Cohort); (v) EPIC Norfolk (High-BMI cases). The TwinsUK
cohort is not represented in the male-specific analysis since the
cohort contains only females.
Found at: doi:10.1371/journal.pgen.1000445.s001 (0.09 MB PDF)
Figure S2 Regional plot of the 17 confirmed associations with
height for SNPs genotyped in the TwinsUK, Rotterdam, 1958
Birth Cohort, EPIC cohort and EPIC cases. Meta-analysis 2log10
P-values are plotted as a function of genomic position (NCBI Build
36). The GWAS P-value for the lead SNP is denoted by a red
diamond. A blue diamond indicates the P-value for the lead SNP
in the replication sample. Proxies are indicated with diamonds of
smaller size, with colours determined from their pairwise r2 values
from HapMap CEU). Red diamonds indicate high LD with the
lead SNP (r2.0.8), orange diamonds indicate moderate LD with
the lead SNP (0.5,r2,0.8), yellow indicates markers in weak LD
with the lead SNP (0.2,r2,0.5), white indicates either no LD with
the lead SNP (r2,0.2), or loci where such information was not
available.
Found at: doi:10.1371/journal.pgen.1000445.s002 (0.69 MB PDF)
Table S1 Distribution of height and skeletal size measurements
in the cohorts included in the study.
Found at: doi:10.1371/journal.pgen.1000445.s003 (0.09 MB PDF)
Table S2 Calculation of effect size for height associations by
cohort. Beta and SE for height values are given in z-score units for
each copy of A1 allele. For family-based cohorts (TwinsUK
Discovery (KCL) and replication (KCL_RP) and Chuvasha)
height z-scores were calculated in a subset of unrelated individuals.
Found at: doi:10.1371/journal.pgen.1000445.s004 (0.15 MB PDF)
Table S3 Gender-specific associations at the 17 validated height
loci.
Found at: doi:10.1371/journal.pgen.1000445.s005 (0.11 MB PDF)
Table S4 Association of height loci with femur length. For each
locus, the meta-analysis P-value was calculated for best analysis on
two cohorts (TwinsUK, N = 2,364 and Chuvasha, N = 1,141).
Univariate and conditional analyses were carried out on a subset
of unrelated TwinsUK samples with available height and femur
length.
Found at: doi:10.1371/journal.pgen.1000445.s006 (0.12 MB PDF)
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